Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline and Locally Advanced Pancreatic Cancer”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Early research (Phase 1)Ended earlyNCT01739439
What this trial is testing

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IIB Pancreatic Cancer+1 more
Fox Chase Cancer Center 6
Very early researchStudy completedNCT02153450
What this trial is testing

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 8
Not applicableNot Yet RecruitingNCT07839676
What this trial is testing

A Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT)

Who this might be right for
Borderline and Locally Advanced Pancreatic Cancer
Fernando Pessoa Canarias University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06538857
What this trial is testing

CEB-01 in Locally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
CEBIOTEX 39
Not applicableUnknownNCT05262452
What this trial is testing

Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy EffectUltrasound Therapy
Seoul National University Hospital 60
Not applicableActive Not RecruitingNCT04423731
What this trial is testing

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaChemotherapy EffectBorderline Resectable Pancreatic Adenocarcinoma+1 more
Oslo University Hospital 251
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Not applicableUnknownNCT03202199
What this trial is testing

Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.

Who this might be right for
Pancreatic Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 125
Large-scale testing (Phase 3)Study completedNCT01458717
What this trial is testing

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 58
Not applicableUnknownNCT05511116
What this trial is testing

Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI

Who this might be right for
Pancreas CancerAdenocarcinoma
Fondation Hôpital Saint-Joseph 48
Early research (Phase 1)Study completedNCT01413022
What this trial is testing

FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
Washington University School of Medicine 44
Testing effectiveness (Phase 2)Ended earlyNCT01688336
What this trial is testing

FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)WithdrawnNCT04481204
What this trial is testing

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03138720
What this trial is testing

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Who this might be right for
Resectable Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma+1 more
HonorHealth Research Institute 40
Large-scale testing (Phase 3)Looking for participantsNCT06714604
What this trial is testing

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic CarcinomaPancreas Cancer+3 more
Sahlgrenska University Hospital 432
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Early research (Phase 1)Looking for participantsNCT06673017
What this trial is testing

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma+1 more
PanTher Therapeutics 26
Not applicableNot Yet RecruitingNCT07325214
What this trial is testing

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic CancerLocally Advanced Pancreatic Cancer
IMGT Co., Ltd. 360
Testing effectiveness (Phase 2)Study completedNCT04669197
What this trial is testing

Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer

Who this might be right for
Untreated Resectable Pancreatic AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma
HonorHealth Research Institute 19
Large-scale testing (Phase 3)WithdrawnNCT03649035
What this trial is testing

Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CancerPancreas Neoplasm
Istituto Clinico Humanitas
Next Page